TL1AL72-L251(rev)

General Information


DRACP ID  DRACP05048

Peptide Name   TL1AL72-L251(rev)

Sequence  YRIPIVRRLQRR

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C72H128N28O15

Absent amino acids  ACDEFGHKMNSTW

Common amino acids  R

Mass  182236

Pl  12.68

Basic residues  5

Acidic residues  0

Hydrophobic residues  4

Net charge  5

Boman Index  -6148

Hydrophobicity  -99.17

Aliphatic Index  121.67

Half Life 
  Mammalian: 2.8 hour
  Yeast: 10 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  135.45

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 20675618

Title  Two functionally distinct isoforms of TL1A (TNFSF15) generated by differential ectodomain shedding

Doi 10.1093/gerona/glq129

Year  2010

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.